Larotaxel
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-125374-1 mg |
| CAS # | 156294-36-9 |
| Pricing | 1 mg, USD $160.0 |
| Synonyms | XRP9881 |
| MWt | 831.9 |
| Formula | C₄₅H₅₃NO₁₄ |
| Biological Activity | Larotaxel (XRP9881) is a taxane analogue with preclinical activity against taxane-resistant breast cancer. Larotaxel (XRP9881) exerts its cytotoxic effect by promoting tubulin assembly and stabilizing microtubules, ultimately leading to cell death by apoptosis. It presents the ability to cross the blood brain barrier and has a much lower affinity for P-glycoprotein 1 than Docetaxel[1][2][3]. |
| Purity | 98.62% |